Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Bluefish Pharmaceuticals AB, P.O. Box 49013, 100 28 Stockholm, Sweden
Venlablue XL 75 mg, prolonged-release capsules, hard.
Pharmaceutical Form |
---|
Prolonged-release capsule, hard. Peach opaque/peach opaque, size ‘1’ hard gelatin capsules having thick and thin radial circular band on the body in red ink and thick and thin radial circular band on the cap in red ink. The capsule is filled with 6 white to off-white, round, biconvex, film coated mini tablets of 12.5 mg each. |
Each capsule contains: Venlafaxine hydrochloride, corresponding to 75 mg Venlafaxine.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Venlafaxine |
Venlafaxine has an antidepressant effect. The mechanism of its action in humans is believed to be associated with its potentiation of neurotransmitter activity in the central nervous system. |
List of Excipients |
---|
Tablet core: Microcrystalline cellulose Tablet film coat: Ethyl cellulose Capsule: Black iron oxide (E172) Printing inks: Shellac |
Blister packs of opaque, white PVC/Aclar film and aluminium foil; 10, 14, 28, 30, 50& 100 capsules
Blister packs of opaque, white PVC/PVdC film and aluminium foil; 10, 14, 28, 30, 50& 100 capsules
Not all pack sizes may be marketed.
Bluefish Pharmaceuticals AB, P.O. Box 49013, 100 28 Stockholm, Sweden
PA1436/006/001
Date of first authorisation: 9th April 2010
Date of last renewal: 18th March 2015
Drug | Countries | |
---|---|---|
VENLABLUE | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.